Minerva Neurosciences, Inc. — Director's Dealing 2014

Jul 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2014-06-30

Reporting Person: Luthringer Remy (EVP and Head of R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-30	Employee Stock Option (Right to Buy)	$6.00	A	441973	Acquired	2024-06-29	Common Stock (441973)	Direct
2014-06-30	Employee Stock Option (Right to Buy)	$6.00	A	207869	Acquired	2024-06-29	Common Stock (207869)	Direct

Footnotes

F1: 25% of the shares subject to the option will become exercisable on November 12, 2014 and the balance of the shares will become exercisable in a series of twelve equal quarterly installments upon Dr. Luthringer's completion of each quarter of service over the three year period thereafter.